Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Of Ireland Regulatory News (BIRG)

Share Price Information for Bank Of Ireland (BIRG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.785
Bid: 9.955
Ask: 10.00
Change: 0.64 (7.00%)
Spread: 0.045 (0.452%)
Open: 9.54
High: 9.935
Low: 9.54
Prev. Close: 9.145
BIRG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results 2020

5 Aug 2020 07:04

RNS Number : 1899V
Bank of Ireland Group PLC
05 August 2020
 

Bank of Ireland Group plc (the "Group")

Publishes Interim Results for the 6 months to 30th June 2020

 

 

5 August 2020

 

CEO Comment: Francesca McDonagh, Bank of Ireland Group CEO:

 

"Our priority in the pandemic has been to proactively support our customers, colleagues and communities, and to stay focussed on delivering our strategy. We put in place a wide range of supports for customers, including more than 100,000 payment breaks in Ireland and the UK, and we transformed how we operate. Notwithstanding the challenges, we've increased our market share in Irish mortgages, reduced costs, and continued to improve our products and services especially through digital.

 

"The severe impact of COVID-19 - on our customers, the economy, and our business - is seen in our first half 2020 results. COVID-19 has had a material impact on the Group's financial performance and outlook. We have taken an impairment charge of €937 million, resulting in a loss before tax of €669 million for the first six months of 2020.

 

"Our capital remains strong and resilient, with a fully loaded CET1 ratio of 13.6% and a regulatory CET1 ratio of 14.9%. Our outlook is cautiously more optimistic than our quarter one trading update, resulting in revised guidance for the rest of 2020 in terms of new lending and business income. We remain committed to continuing to support our customers, and helping reboot the economy, in the time ahead."

 

H1 2020 Financials:

· Strong capital position; fully loaded CET1 capital ratio 13.6%, regulatory CET1 capital ratio 14.9%

· Underlying loss of €669 million

· Total income 13% lower; net interest income stable; NIM of 2.02%

· Strong cost discipline; net reduction 3% / €31 million

· IFRS 9 impairment charge €937 million; a prudent and comprehensive approach

· Net lending growth of €0.2 billion including €1.3 billion of revolving credit facilities

· Pre-impairment organic capital generation of 45 basis points

 

Income Statement

Net interest income (NII) of €1.1 billion was broadly in line with the first half of 2019. Net interest margin was 2.02%, in line with our expectations. The Group's NII reflects the benefit from loan book growth since 2017 and reduced liability costs offsetting lower structural hedge income and UK competitive pressures.

 

Fees and other income arise from diversified business activities including wealth, bancassurance, foreign exchange and transactional banking fees. This includes business income of €266 million which is 14% lower than the same period in 2019 due to the disruption caused by COVID-19. Wealth and Insurance income decreased 16% versus the same period in 2019 from lower new business sales and reduced income on existing business. While Retail Ireland income decreased 20% from reduced current account and FX income and lower levels of card transactions as a result of the economic lockdown.

 

A loss of €109 million on valuations and other items was reported in the first six months. This reflected falling equity markets and widening credit spreads related to unit linked assets and bond portfolio valuations in Wealth and Insurance of €90 million, and financial instrument valuation adjustments and other items of €19 million.

 

Delivery on transforming our culture, systems and business model continues to drive efficiencies across the Group. Operating expenses (excluding levies and regulatory charges and impairment of goodwill) reduced by 3% compared to the first half of 2019 and includes COVID-19 related expenses. Expenses reduced by 5% excluding COVID-19 related expenses.

 

A net credit impairment charge of €937 million in the first six months of 2020 compared to €79 million in the same period of 2019. This charge, largely taken on Stage 1 and Stage 2 performing loans, includes €432 million from the impact on IFRS 9 models from the Group's latest macro-economic outlook, a €184 million management adjustment related to payment breaks, and €321 million from actual loan loss experience in the period. The Group's impairment coverage increased to 2.7% from 1.6% at December 2019 resulting in an impairment loss allowance of €2.1 billion on balance sheet at June 2020.

 

Non-core charges of €153 million include €136 million impairment relating to intangible software assets. This charge was incurred following a review of the recoverability of assets.

 

Balance Sheet

The Group's loan book decreased by €2.8 billion during the first six months of 2020 (€0.5 billion on a constant currency basis). Net lending growth of €0.2 billion includes €1.3 billion of revolving credit facility (RCF) drawdowns, with mortgage market share in Ireland increasing to 25%. Foreign exchange and other movements of €2.1 billion and impairment charges more than offset net lending. Total new lending volumes, excluding RCF activity, of €5.8 billion were 19% lower than the first half of 2019, reflecting reduced activity in our core markets as a consequence of COVID-19.

 

Our non-performing exposures (NPE) increased by €1.1 billion to €4.6 billion, equating to an NPE ratio of 5.8% of gross customer loans. This increase primarily reflects credit migration in our corporate and property and construction portfolios, and the implementation of the new Definition of Default regulatory framework.

 

Capital

Our fully loaded CET1 capital ratio of 13.6% at June 2020 remains strong, with a 10 basis point improvement since quarter one 2020. Pre-impairment organic capital generation and the reversal of the dividend declared in respect of 2019 was offset by the impact of credit deterioration, loan book growth, transformation investment and regulatory capital demand. Minimum regulatory capital requirements have been reduced by 218 basis points to 9.27% in 2020 and the Group's regulatory CET1 capital ratio of 14.9% at June provides headroom of c.560 basis points. No dividend deduction has been assumed for 2020.

 

Outlook

· 2020 gross new lending volumes are expected to be c.70% of 2019 volumes

· Net interest income in 2020 to be c.5% lower than 2019

· 2020 business income to be 20%-30% lower than 2019

· Costs will continue to reduce; 2020 costs to be lower than 2019, and 2021 costs to be below previous guidance of €1.65 billion

· While we expect economic recovery commencing in H2 2020, COVID-19 and Brexit are ongoing uncertainties, subject to no further deterioration in the economic environment or outlook, 2020 impairment charge expected to be in a range of c.€1.1 billion to €1.3 billion

· 2020 regulatory CET1 ratio to remain above 13.5%, no dividend deduction assumed for 2020

· The longer term impacts of COVID-19 on the economy and the Group's financial performance remain uncertain; our medium-term targets should therefore no longer be considered current in these circumstances

 

Ends

 

http://www.rns-pdf.londonstockexchange.com/rns/1899V_1-2020-8-5.pdf

 

For further information log on to www.bankofireland.com/investor or contact:

 

Bank of Ireland

 

Myles O'Grady, Group Chief Financial Officer +353 (0)766 24 3291

Darach O'Leary, Head of Group Investor Relations +353 (0)766 24 4711

Damien Garvey, Head of Group External Communications and Public Affairs +353 (0)766 24 6716

 

 

 

Forward-Looking Statement

This announcement contains forward-looking statements with respect to certain of Bank of Ireland Group plc ('BOIG plc') and its subsidiaries' (collectively the 'Group') plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal,' 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.

 

Examples of forward-looking statements include, among others: statements regarding the Group's near term and longer term future capital requirements and ratios, level of ownership by the Irish Government, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, future payment of dividends, the implementation of changes in respect of certain of the Group's pension schemes, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations. Such forward-looking statements are inherently subject to risks and uncertainties, and hence actual results may differ materially from those expressed or implied by such forward-looking statements.

 

Nothing in this announcement should be considered to be a forecast of future profitability, dividends or financial position of the Group and none of the information in this announcement is or is intended to be a profit forecast, dividend forecast or profit estimate. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR EASPSESEEEEA
Date   Source Headline
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:35 amRNSNotification of Major Holdings
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20241:35 pmRNSNotification of Major Holdings
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:14 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20243:45 pmRNSNotification of Major Holdings
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20241:51 pmRNSFinal Dividend
1st Mar 202410:18 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20244:35 pmRNSNotification of Major Holdings
27th Feb 202412:55 pmRNSNotification of Changes in Director’s Details
27th Feb 20247:02 amRNSShare Buyback Programme Commencement
26th Feb 20247:00 amRNSBank of Ireland Annual Results 31 December 2023
2nd Feb 20243:25 pmRNSNotification of Major Holdings
12th Jan 20242:48 pmRNSDirectorate Change
12th Dec 20239:17 amRNSPost-Stabilisation Notice
11th Dec 20239:41 amRNSNotice of the Redemption of Preference Stock
8th Dec 20238:04 amRNSChange in Director Responsibilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.